CVE-2026-34324: Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data. in Oracle Corporation Oracle Life Sciences InForm
CVE-2026-34324 is a vulnerability in Oracle Life Sciences InForm versions 7. 0. 1. 0 and 7. 0. 1. 1 that allows an unauthenticated attacker with network access via HTTP to perform unauthorized read and write operations on accessible data. The vulnerability impacts confidentiality and integrity but does not affect availability. It has a CVSS 3. 1 base score of 6.
AI Analysis
Technical Summary
This vulnerability affects the App Server component of Oracle Life Sciences InForm versions 7.0.1.0 and 7.0.1.1. It allows an unauthenticated attacker with network access via HTTP to compromise the system, resulting in unauthorized update, insert, or delete access to some accessible data, as well as unauthorized read access to a subset of accessible data. The CVSS 3.1 vector (AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N) indicates network attack vector, low attack complexity, no privileges or user interaction required, unchanged scope, and impacts on confidentiality and integrity but not availability. The vulnerability is categorized under CWE-284 (Improper Access Control). Oracle’s April 2026 Critical Patch Update advisory references multiple patches but does not explicitly list a patch for this specific vulnerability or product version, leaving patch status unconfirmed.
Potential Impact
Successful exploitation can lead to unauthorized reading and modification (update, insert, delete) of some data accessible through Oracle Life Sciences InForm, compromising confidentiality and integrity of that data. There is no impact on system availability. The vulnerability can be exploited remotely without authentication, increasing risk if the affected versions are exposed to untrusted networks. No known exploits in the wild have been reported so far.
Mitigation Recommendations
Oracle’s April 2026 Critical Patch Update advisory strongly recommends applying available security patches promptly. However, the advisory does not explicitly confirm a patch for Oracle Life Sciences InForm versions 7.0.1.0 or 7.0.1.1 for this vulnerability. Therefore, patch status is not yet confirmed—check the vendor advisory at https://www.oracle.com/security-alerts/cpuapr2026.html for the latest remediation guidance. Until a patch is confirmed and applied, restrict network access to the affected Oracle Life Sciences InForm instances to trusted users only and monitor for unusual activity related to data access. Follow Oracle’s guidance for maintaining supported versions and applying Critical Patch Updates without delay.
CVE-2026-34324: Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data. in Oracle Corporation Oracle Life Sciences InForm
Description
CVE-2026-34324 is a vulnerability in Oracle Life Sciences InForm versions 7. 0. 1. 0 and 7. 0. 1. 1 that allows an unauthenticated attacker with network access via HTTP to perform unauthorized read and write operations on accessible data. The vulnerability impacts confidentiality and integrity but does not affect availability. It has a CVSS 3. 1 base score of 6.
CVSS v3.1
Score 6.5medium
Weaknesses
AI-Powered Analysis
Machine-generated threat intelligence
Technical Analysis
This vulnerability affects the App Server component of Oracle Life Sciences InForm versions 7.0.1.0 and 7.0.1.1. It allows an unauthenticated attacker with network access via HTTP to compromise the system, resulting in unauthorized update, insert, or delete access to some accessible data, as well as unauthorized read access to a subset of accessible data. The CVSS 3.1 vector (AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N) indicates network attack vector, low attack complexity, no privileges or user interaction required, unchanged scope, and impacts on confidentiality and integrity but not availability. The vulnerability is categorized under CWE-284 (Improper Access Control). Oracle’s April 2026 Critical Patch Update advisory references multiple patches but does not explicitly list a patch for this specific vulnerability or product version, leaving patch status unconfirmed.
Potential Impact
Successful exploitation can lead to unauthorized reading and modification (update, insert, delete) of some data accessible through Oracle Life Sciences InForm, compromising confidentiality and integrity of that data. There is no impact on system availability. The vulnerability can be exploited remotely without authentication, increasing risk if the affected versions are exposed to untrusted networks. No known exploits in the wild have been reported so far.
Mitigation Recommendations
Oracle’s April 2026 Critical Patch Update advisory strongly recommends applying available security patches promptly. However, the advisory does not explicitly confirm a patch for Oracle Life Sciences InForm versions 7.0.1.0 or 7.0.1.1 for this vulnerability. Therefore, patch status is not yet confirmed—check the vendor advisory at https://www.oracle.com/security-alerts/cpuapr2026.html for the latest remediation guidance. Until a patch is confirmed and applied, restrict network access to the affected Oracle Life Sciences InForm instances to trusted users only and monitor for unusual activity related to data access. Follow Oracle’s guidance for maintaining supported versions and applying Critical Patch Updates without delay.
Technical Details
- Data Version
- 5.2
- Assigner Short Name
- oracle
- Date Reserved
- 2026-03-26T19:48:45.682Z
- Cvss Version
- 3.1
- State
- PUBLISHED
- Remediation Level
- null
- Vendor Advisory Urls
- [{"url":"https://www.oracle.com/security-alerts/cpuapr2026.html","vendor":"Oracle"}]
Threat ID: 69e7e5ad19fe3cd2cdfa00c4
Added to database: 4/21/2026, 9:01:33 PM
Last enriched: 4/29/2026, 11:18:39 AM
Last updated: 6/6/2026, 8:52:20 AM
Views: 69
Community Reviews
0 reviewsCrowdsource mitigation strategies, share intel context, and vote on the most helpful responses. Sign in to add your voice and help keep defenders ahead.
Want to contribute mitigation steps or threat intel context? Sign in or create an account to join the community discussion.
Actions
Updates to AI analysis require Pro Console access. Upgrade inside Console → Billing.
External Links
Need more coverage?
Upgrade to Pro Console for AI refresh and higher limits.
For incident response and remediation, OffSeq services can help resolve threats faster.
Latest Threats
Check if your credentials are on the dark web
Instant breach scanning across billions of leaked records. Free tier available.